| 标题 |
Nivolumab (nivo) plus ipilimumab (ipi), nivo, or placebo (pbo) as maintenance therapy in patients (pts) with extensive disease small cell lung cancer (ED-SCLC) after first-line (1L) platinum-based chemotherapy (chemo): Results from the double-blind, randomized phase III CheckMate 451 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:T.K. Owonikoko; H.R. Kim; R. Govindan; N. Ready; M. Reck; et al 出版日期:2019-04-13 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)